Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate

This article was originally published here

As part of the agreement, Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24×7 manufacturing operations at the site to support

The post Moderna and Catalent announce collaboration for fill-finish manufacturing of Moderna’s Covid-19 vaccine candidate appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply